Genedata Expressionist® enables biopharma to leverage the sensitivity and molecular insights provided by mass spectrometry for in-depth characterization and quality monitoring of RNA and oligonucleotide therapeutics.
Flexible. Automated. Compliance-Ready.
The structural complexity and multistep production processes of oligonucleotide-based drugs require advanced MS analytical methods for in-depth characterization and stringent quality monitoring.
Genedata Expressionist® provides a flexible platform for streamlining MS data processing, analysis, and reporting throughout the development of RNA-based therapeutics, from early discovery to downstream regulated environments.
Discover how scientists at Roche overcame major data processing bottlenecks in therapeutic oligonucleotide process development.
Automating Therapeutic Oligonucleotide QC
"Genedata developed the end-to-end oligonucleotide QC data workflow and provided the consulting expertise throughout the entire project including the validation stage to help us achieve our goals on time and within budget."
Automating MS-Based Analytics of Novel Therapeutic Oligos
"By reducing analysis time from 5–6 hours to less than 30 minutes per sample, Genedata Expressionist enabled us to overcome a major bottleneck in our analytical support of process development."